Work

Supplementary Figure 2 from CDK Inhibitors Upregulate BH3-Only Proteins to Sensitize Human Myeloma Cells to BH3 Mimetic Therapies

Year: 2023
Type: supplementary-materials
Abstract: PDF file - 140K, FP/obatoclax down-regulates Bcl-xL, but not Bcl-2, which plays a partial role in this regimen
Language: English
Open Access status: gold
OpenAlex ID: W4361845847
Cites:
Cited by:
Related to: 10